A delayed rebound in the Australian pathology market following government funding cuts has forced Sonic Healthcare to lower the bottom end of its earnings guidance for 2011.

MEDICAL diagnostics company Sonic Healthcare's share price dropped by 2 per cent yesterday despite a forecast of a 15 per cent improvement this year.

Strong earnings are warming investor hearts as the days grow colder -- and the urge to merge among companies offers support.